Actual Medicinal Product (AMP) Anzipro 375mg modified-release tablets (Ridge Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Notes

No special precautions for storage.

Generic
Ranolazine
Formulation
Ranolazine 375mg modified-release tablets
  • Ranolazine
    • Ranolazine 375mg modified-release tablets

      • Anzipro 375mg modified-release tablets (Ridge Pharma Ltd)

Alternative Suppliers (13)

Ranexa 375mg modified-release tablets (A. Menarini Farmaceutica Internazionale SRL)
Ranexa 375mg modified-release tablets (CST Pharma Ltd)
Ranexa 375mg modified-release tablets (DE Pharmaceuticals)
Ranolazine 375mg modified-release tablets (Teva UK Ltd)
Ranolazine 375mg modified-release tablets (Krka UK Ltd)
Ranolazine 375mg modified-release tablets (Celix Pharma Ltd)
Ranolazine 375mg modified-release tablets (A A H Pharmaceuticals Ltd)
Ranolazine 375mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Anzipro 375mg modified-release tablets (Ridge Pharma Ltd)
Ranexa 375mg modified-release tablets (Waymade Healthcare Plc)
Ranexa 375mg modified-release tablets (Ethigen Ltd)
Ranogelan 375mg prolonged-release tablets (G.L. Pharma UK Ltd)
Ranolazine 375mg modified-release tablets (Dr Reddy's Laboratories (UK) Ltd)